Advances in multiple myeloma therapy during two past decades

Yazar: Spicka, Ivan
Baskı/Yayın Bilgisi 2014

Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report

Yazar: Klanova, Magdalena, Klener, Pavel, Trneny, Marek, Straub, Jan, Spicka, Ivan
Baskı/Yayın Bilgisi 2012

Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma

Yazar: Fassmannová, Dominika, Sedlák, František, Sedláček, Jindřich, Špička, Ivan, Grantz Šašková, Klára
Yayımlandı Cancers (Basel) (2020)

Whole-body low-dose computed tomography in multiple myeloma staging: Superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fracture...

Yazar: Lambert, Lukas, Ourednicek, Petr, Meckova, Zuzana, Gavelli, Giampaolo, Straub, Jan, Spicka, Ivan
Yayımlandı Oncol Lett (2017)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma

Yazar: Hájek, Roman, Delforge, Michel, Raab, Marc S., Schoen, Paul, DeCosta, Lucy, Spicka, Ivan, Radocha, Jakub, Pour, Ludek, Gonzalez‐McQuire, Sebastian, Bouwmeester, Walter
Yayımlandı Br J Haematol (2019)

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

Yazar: Ludwig, Heinz, Adam, Zdenek, Tóthová, Elena, Hajek, Roman, Labar, Boris, Egyed, Miklós, Spicka, Ivan, Gisslinger, Heinz, Drach, Johannes, Kuhn, Ingrid, Hinke, Axel, Zojer, Niklas
Baskı/Yayın Bilgisi 2010

A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Yazar: Hajek, Roman, Pour, Ludek, Ozcan, Muhit, Martin Sánchez, Jesus, García Sanz, Ramon, Anagnostopoulos, Achilles, Oriol, Albert, Cascavilla, Nicola, Terjung, Andreas, Lee, Yihua, Briso, Eva M., Dobkowska, Edyta, Hauns, Bernhard, Špička, Ivan
Yayımlandı Eur J Haematol (2020)

Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin With Bortezomib Alone in Patients With Relapsed or Refractory Multipl...

Yazar: Orlowski, Robert Z., Nagler, Arnon, Sonneveld, Pieter, Bladé, Joan, Hajek, Roman, Spencer, Andrew, Robak, Tadeusz, Dmoszynska, Anna, Horvath, Noemi, Spicka, Ivan, Sutherland, Heather J., Suvorov, Alexander N., Xiu, Liang, Cakana, Andrew, Parekh, Trilok, San-Miguel, Jesús F.
Yayımlandı Cancer (2016)

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up

Yazar: Ludwig, Heinz, Greil, Richard, Masszi, Tamas, Spicka, Ivan, Shpilberg, Ofer, Hajek, Roman, Dmoszynska, Anna, Paiva, Bruno, Vidriales, María‐Belén, Esteves, Graca, Stoppa, Anne Marie, Robinson, Don, Chaturvedi, Shalini, Ataman, Ozlem, Enny, Christopher, Feng, Huaibao, van de Velde, Helgi, Viterbo, Luisa
Yayımlandı Br J Haematol (2015)

A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagn...

Yazar: San-Miguel, Jesús F., Echeveste Gutierrez, Maria-Asunción, Špicka, Ivan, Mateos, María-Victoria, Song, Kevin, Craig, Michael D., Bladé, Joan, Hájek, Roman, Chen, Christine, Di Bacco, Alessandra, Estevam, Jose, Gupta, Neeraj, Byrne, Catriona, Lu, Vickie, van de Velde, Helgi, Lonial, Sagar
Yayımlandı Haematologica (2018)

Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial

Yazar: Dimopoulos, Meletios A., Špička, Ivan, Quach, Hang, Oriol, Albert, Hájek, Roman, Garg, Mamta, Beksac, Meral, Bringhen, Sara, Katodritou, Eirini, Chng, Wee-Joo, Leleu, Xavier, Iida, Shinsuke, Mateos, María-Victoria, Morgan, Gareth, Vorog, Alexander, Labotka, Richard, Wang, Bingxia, Palumbo, Antonio, Lonial, Sagar
Yayımlandı J Clin Oncol (2020)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies

Yazar: Radocha, Jakub, Maisnar, Vladimír, Pour, Luděk, Špička, Ivan, Minařík, Jiři, Szeligová, Lenka, Pavlíček, Petr, Jungová, Alexandra, Krejčí, Marta, Pika, Tomáš, Straub, Jan, Brožová, Lucie, Stejskal, Lukáš, Heindorfer, Adriana, Jindra, Pavel, Kessler, Petr, Mikula, Peter, Sýkora, Michal, Wróbel, Marek, Jarkovský, Jiří, Hájek, Roman
Yayımlandı Cancer Med (2018)

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

Yazar: Dimopoulos, Meletios A., Stewart, A. Keith, Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David, Mihaylov, Georgi G., Goranova‐Marinova, Vesselina, Rajnics, Péter, Suvorov, Aleksandr, Niesvizky, Ruben, Jakubowiak, Andrzej, San‐Miguel, Jesus, Ludwig, Heinz, Palumbo, Antonio, Obreja, Mihaela, Aggarwal, Sanjay, Moreau, Philippe
Yayımlandı Br J Haematol (2017)

Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexam...

Yazar: Stewart, A. Keith, Dimopoulos, Meletios A., Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David S., Niesvizky, Ruben, Jakubowiak, Andrzej J., San-Miguel, Jesus F., Ludwig, Heinz, Buchanan, Jacqui, Cocks, Kim, Yang, Xinqun, Xing, Biao, Zojwalla, Naseem, Tonda, Margaret, Moreau, Philippe, Palumbo, Antonio
Yayımlandı J Clin Oncol (2016)

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Yazar: Mikhael, Joseph, Belhadj-Merzoug, Karim, Hulin, Cyrille, Vincent, Laure, Moreau, Philippe, Gasparetto, Cristina, Pour, Ludek, Spicka, Ivan, Vij, Ravi, Zonder, Jeffrey, Atanackovic, Djordje, Gabrail, Nashat, Martin, Thomas G., Perrot, Aurore, Bensfia, Samira, Weng, Qilong, Brillac, Claire, Semiond, Dorothée, Macé, Sandrine, Corzo, Kathryn P., Leleu, Xavier
Yayımlandı Blood Cancer J (2021)

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neurop...

Yazar: Minarik, Jiri, Pavlicek, Petr, Pour, Ludek, Pika, Tomas, Maisnar, Vladimir, Spicka, Ivan, Jarkovsky, Jiri, Krejci, Marta, Bacovsky, Jaroslav, Radocha, Jakub, Straub, Jan, Kessler, Petr, Wrobel, Marek, Walterova, Lenka, Sykora, Michal, Obernauerova, Jarmila, Brozova, Lucie, Gregora, Evzen, Adamova, Dagmar, Gumulec, Jaromir, Adam, Zdenek, Scudla, Vlastimil, Hajek, Roman
Yayımlandı PLoS One (2015)

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL-6 mAb) and Bortezomib versus Bortezomib Alone in Patients with Relapsed or Refractory Multiple...

Yazar: Orlowski, Robert Z., Gercheva, Liana, Williams, Cathy, Sutherland, Heather, Robak, Tadeusz, Masszi, Tamás, Goranova-Marinova, Vesselina, Dimopoulos, Meletios A., Cavenagh, James D., Špička, Ivan, Maiolino, Angelo, Suvorov, Alexander, Bladé, Joan, Samoylova, Olga, Puchalski, Thomas A., Reddy, Manjula, Bandekar, Rajesh, van de Velde, Helgi, Xie, Hong, Rossi, Jean-François
Yayımlandı Am J Hematol (2015)

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth...

Yazar: Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Palumbo, Antonio, San‐Miguel, Jesus, Shpilberg, Ofer, Anderson, Kenneth, Grosicki, Sebastian, Spicka, Ivan, Walter‐Croneck, Adam, Magen, Hila, Mateos, Maria‐Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Bleickardt, Eric, Poulart, Valerie, Sheng, Jennifer, Sy, Oumar, Katz, Jessica, Singhal, Anil, Richardson, Paul
Yayımlandı Br J Haematol (2017)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Yazar: Spicka, Ivan, Ocio, Enrique M., Oakervee, Heather E., Greil, Richard, Banh, Raymond H., Huang, Shang-Yi, D’Rozario, James M., Dimopoulos, Meletios A., Martínez, Sara, Extremera, Sonia, Kahatt, Carmen, Alfaro, Vicente, Carella, Angelo M., Meuleman, Nathalie, Hájek, Roman, Symeonidis, Argiris, Min, Chang-Ki, Cannell, Paul, Ludwig, Heinz, Sonneveld, Pieter, Mateos, María Victoria
Yayımlandı Ann Hematol (2019)

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical...

Yazar: Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brozova, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukas, Heindorfer, Adriana, Ullrychova, Jana, Skacel, Tomas, Maisnar, Vladimir, Hajek, Roman
Yayımlandı BMC Cancer (2021)